Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IBEX (IBEX) Shares Outstanding (Weighted Average): 2019-2025

Historic Shares Outstanding (Weighted Average) for IBEX (IBEX) over the last 4 years, with Sep 2025 value amounting to $13.3 million.

  • IBEX's Shares Outstanding (Weighted Average) fell 20.76% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year decrease of 20.76%. This contributed to the annual value of $13.4 million for FY2025, which is 22.32% down from last year.
  • According to the latest figures from Q3 2025, IBEX's Shares Outstanding (Weighted Average) is $13.3 million, which was down 0.43% from $13.4 million recorded in Q2 2025.
  • IBEX's Shares Outstanding (Weighted Average)'s 5-year high stood at $18.3 million during Q3 2023, with a 5-year trough of $13.2 million in Q1 2025.
  • In the last 3 years, IBEX's Shares Outstanding (Weighted Average) had a median value of $17.2 million in 2024 and averaged $16.4 million.
  • As far as peak fluctuations go, IBEX's Shares Outstanding (Weighted Average) grew by 3.21% in 2021, and later declined by 24.93% in 2025.
  • Quarterly analysis of 5 years shows IBEX's Shares Outstanding (Weighted Average) stood at $18.1 million in 2021, then grew by 0.93% to $18.1 million in 2022, then declined by 1.11% to $17.9 million in 2023, then fell by 6.54% to $16.8 million in 2024, then decreased by 20.76% to $13.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $13.3 million for Q3 2025, versus $13.4 million for Q2 2025 and $13.2 million for Q1 2025.